Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 223.4 SEK -2.27% Market Closed
Market Cap: 30.2B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Vitrolife AB
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vitrolife AB
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Vitrolife AB
STO:VITR
Free Cash Flow
kr655m
CAGR 3-Years
8%
CAGR 5-Years
14%
CAGR 10-Years
16%
Biogaia AB
STO:BIOG B
Free Cash Flow
kr377.4m
CAGR 3-Years
23%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Free Cash Flow
-kr3m
CAGR 3-Years
68%
CAGR 5-Years
56%
CAGR 10-Years
N/A
Probi AB
STO:PROB
Free Cash Flow
kr29.7m
CAGR 3-Years
-43%
CAGR 5-Years
-25%
CAGR 10-Years
8%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Free Cash Flow
kr3.3B
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
38%
BioArctic AB
STO:BIOA B
Free Cash Flow
kr302.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Vitrolife AB
Glance View

Market Cap
30.2B SEK
Industry
Biotechnology

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 427 full-time employees. The company went IPO on 2001-06-26. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. The company also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The firm is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

VITR Intrinsic Value
140.46 SEK
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Vitrolife AB's Free Cash Flow?
Free Cash Flow
655m SEK

Based on the financial report for Sep 30, 2024, Vitrolife AB's Free Cash Flow amounts to 655m SEK.

What is Vitrolife AB's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
16%

Over the last year, the Free Cash Flow growth was 1%. The average annual Free Cash Flow growth rates for Vitrolife AB have been 8% over the past three years , 14% over the past five years , and 16% over the past ten years .

Back to Top